Description of Activity
Over the last several years, there have been a multitude of new therapeutic drugs for the management of migraine and several real world studies assessing the management of various aspects of migraine. This collection of articles include manuscripts published on real world evidence in the past two years in Headache: The Journal of Head and Face Pain.
Objective
To understand the current state of migraine management through the review of real world evidence studies on migraine in the last 2 years.
Activity Disclosures
No commercial support has been accepted related to the development or publication of this activity.
Faculty disclose no financial relationships. This activity underwent peer review in line with standards of editorial integrity and publication ethics. Conflicts of interest have been identified and resolved in accordance with John Wiley and Sons, Inc.’s Policy on Activity Disclosure and Conflict of Interest.
COI of CME activity authors
Arathi Nandyala, MD
Conflict of Interest Statement:
Dr. Nandyala reports no conflicts of interest.
Keiko Ihara, MD
Conflict of Interest Statement:
Dr. Ihara receives Postdoctoral Fellowship Grant from the American Heart Association with funds paid to her institution.
Minali Nigam, MD
Conflict of Interest Statement:
Dr. Nigam reports no conflicts of interest.
Edina Szabo, MD
Conflict of Interest Statement:
Dr. Szabo reports no conflicts of interest.
Accreditation
John Wiley & Sons, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
John Wiley and Sons, Inc. designates this journal-based CME activity for a maximum of 4.5 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity. For information on applicability and acceptance of continuing medical education credit for this activity, please consult your professional licensing board.
The American Board of Psychiatry and Neurology has reviewed Behavior and Migraine and has approved this activity as part of a comprehensive Self-Assessment activity, which is mandated by the ABMS as a necessary component of Continuing Certification.
This activity is designed to be completed within 4.5 hours. To successfully earn credit, participants must access and complete the activity during the valid credit period, which is up to two years from initial publication.
Link to content: Real-world studies in migraine
Subscription access to Headache: The Journal of Head and Face Pain is required for article content not under Open Access license.
AHS members may access the journal through their membership portal. Please visit the American Headache Society website for more information on becoming a member.
